Skip to main content
. Author manuscript; available in PMC: 2010 May 4.
Published in final edited form as: J Urol. 2009 Oct 17;182(6):2819–2824. doi: 10.1016/j.juro.2009.08.086

Table 4. Association between LUTS/BPE medication use and IPP.

Unadjusted OR (95% CI) Adjusted OR (95% CI)*
IPP (mm):
 Less than 10 1.00 1.00
 10 or Greater 3.25 (1.53–6.93) 2.95 (1.23–7.06)
Age:
 50–59 1.00 1.00
 60–69 0.89 (0.42–1.88) 0.94 (0.42–2.15)
 70+ 2.18 (1.03–4.64) 1.52 (0.66–3.51)
Symptom score:
 7 or Less 1.00 1.00
 Greater than 7 6.00 (3.01–11.95) 3.37 (1.43–7.98)
Bother score:
 3 or Less 1.00 1.00
 Greater than 3 3.86 (2.17–6.88) 1.95 (0.94–4.05)
Peak flow rate (ml/sec):
 12 or Greater 1.00 1.00
 Less than 12 2.33 (1.33–4.07) 1.38 (0.74–2.57)
Prostate vol (ml):
 30 or Less 1.00 1.00
 Greater than 30 2.28 (1.29–4.02) 1.56 (0.82–3.00)
*

Odds ratios adjusted for all variables in the table.